Monday, October 21, 2019 12:54:15 PM
Monday, October 21, 2019 12:43 PM
Stillcanna's Nexus Facility Produces Pharmaceutical Grade CBD Isolate in Poland
VANCOUVER, BC / ACCESSWIRE / Monday October 21, 2019 / Stillcanna Inc. (OTC:SCNNF) (CSE:STIL) (FRANKFURT:A2PEWA) ("STIL" or the "Company") is pleased to announce that its NEXUS extraction facility has produced bulk CBD isolate from hemp harvested by Olimax, the Company's farming subsidiary in Poland.
With the use of Stillcanna's proprietary operating procedures, CBD rich honey oil distillate is further purified into pharmaceutical grade CBD isolate. The successful manufacturing of the CBD isolate in the NEXUS facility is THC, pesticide and heavy metal free.
The Company is expected to begin shipping samples of its pharmaceutical grade CBD isolate to its current and potential customers as a part of its standard sales process this quarter. The Company is still on track for commercial production of CBD this quarter to begin fulfilling its contractual agreements.
https://www.accesswire.com/563591/Stillcanna-Produces-Premium-Grade-CBD-Isolate-in-Poland
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM